Amryt Pharma (AMYT)
Amryt Pharma is a specialty biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases. The Company is building a diversified portfolio of commercially attractive, best-in-class, proprietary new drugs to help address some of these rare and debilitating illnesses for which there are currently no available treatments.
Mercia Fund Management (MERC)
Mercia Fund Management (MERC) is now known as Mercia Fund Managers or Mercia is part of Mercia Technologies PLC. It is a UK-based venture capital fund manager. The company provides venture capital to businesses focused on innovative technologies.
Surface Transforms (SCE)
Surface Transforms are experts in the development and production of carbon-ceramic materials and the UK’s only manufacturer of carbon-ceramic brakes for automotive use. ST utilises our proprietary next-generation carbon-ceramic material - CCST - to create lightweight brake discs for high-performance applications, including automotive and aircraft brakes. Surface Transforms has extensive in-house engineering and manufacturing capabilities, including the facilities for manufacturing carbon-ceramic brake discs.